Introduction Treatment of large and giant intracranial aneurysms are often associated with larger complications rates, related to hemodynamic changes of intracranial flow distal to the intracranial aneurysms. In this paper we evaluated the baseline contrast transit times on angiography for patients with proximal anterior circulation aneurysms. Methods Medical charts and digital subtraction angiographic (DSA) films for patients with intracranial aneurysms were reviewed. Only proximal, unruptured anterior circulations aneurysms were included. DSA images were analyzed over M1 segment, using custom made software for the time-density. Analysis included TT 10%-100% (time needed for the contrast to change from 10%-100% image intensity), TT 100%-10% (time needed for the contrast to change from 100%-10% image intensity), and TT 25%-25% (time needed for the contrast to change from 25%-25% image intensity. This was compared to the contralateral M1 transit times. Results A total of 50 patients were included in this study. Aneurysm size ranged from 2-40 mm, mean 12 mm. Analysis over the M1 segment showed a significant increase in the TT 25%-25% (7.6 to 8.46 seconds, P = 0.006) compared to the contralateral side. There was significant correlation (Spearman's correlation) between the TT 10%-100% , the TT 25%-25% and the aneurysm size (rho = 0.291, 0.362 and P = 0.041, 0.01 respectively) (Figure 1 ), indicating a slower contrast time in larger aneurysms. Similarly, there was significant correlation between the absolute difference between the ipsilateral and contralateral TTs and aneurysm size (TT 10%-100% : P = 0.005, rho = 0.393; TT 25%-25% : P < 0.001, rho = 0.52) (Figure 2 ). Conclusion Our analysis shows that statistically significant difference in the intracranial contrast TT as a function of proximal aneurysm size. The mechanism for this might be related to the Windkessel effect where the aneurysm as a blood reservoir in systole and partially release the contrast in diastole. Changes to this baseline phenomenon might contribute to complications post flow diverters implementation. Introduction Carotid stenting (CAS) has been widely used since the seminal CREST trial, demonstrating equivalent results to carotid endarterectomy (CEA). With normal surgical risk patients having symptomatic or asymptomatic carotid artery disease, CAS and CEA, in qualified hands, have comparable outcomes, but patient-specific risk factors to estimate functional outcome were poorly studied. In practice, the choice between CEA and CAS is based on lesion anatomy and preference of patient and surgeon rather than considering defined risk factors associated with unfavorable outcome. We aimed to determine medical risk factors for poor functional outcome after CAS using the Healthcare Cost and Utilization Project Nationwide Inpatient Sample database (NIS) and formulate outcome prediction model to estimate unfavorable functional outcome. Methods We included 29,453 patients (age > 18) with symptomatic and asymptomatic carotid artery disease from 2005 to 2013, who underwent CAS using ICD-9 procedure code and diagnosis code for chronic and acute comorbidity as well as administration data including social economic and demographic profiles. Applying the non-parametric Jonckheere-Terpstra test, Multiple logistic regression, and multiple linear regression analyzes (SAS 9.4; SPSS 22) to formulate outcome prediction model using covariates for (1) Socio-economic status; age, sex and race, (2) chronic comorbidities; hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, congestive heart failure, atrial fibrillation/ flutter, COPD, chronic kidney disease, aortic/visceral/peripheral atherosclerosis, tobacco/alcohol dependence and morbid obesity, (3) care complexity; number of comorbidities, numbers of inpatient diagnosis/ procedures and (4) Acute comorbidities; acute myocardial infarct, acute kidney failure, pneumonia, acute respiratory failure and sepsis. We compared outcome markers which were defined as (1) procedure related stroke, (2) mortality, and (3) functional outcome based on discharge disposition; long term facility or not. Care complexity and acute comorbidities were also considered for outcome analysis without utilization for Introduction The Solitaire (Medtronic, Minneapolis, MN) is a stentriever device for endovascular treatment of acute ischemic stroke (AIS). The Solitaire is well described for use in temporary endovascular bypass, and mechanical thrombectomy. Permanent placement of the Solitaire is an option, but there are limited reports to date. The authors of this study review six cases of Solitaire stent implantation in the setting of large vessel occlusion and acute ischemic stroke, where temporary endovascular bypass and mechanical thrombectomy failed. Materials and methods Six cases of failed mechanical thrombectomy are reviewed, including procedural review, timing of anti-platelet agents, and radiographic and clinical outcomes. Results Six patients with severe, acute ischemic stroke (AIS) and large vessel occlusion (LVO) were triaged to mechanical thrombectomy. Despite multiple attempts at mechanical thrombus retrieval with a combination of devices including stentrievers and direct thrombus aspiration, flow could not be restored. As a bailout maneuver, the Solitaire stent was deployed and detached across the thrombus with TICI grade
in larger aneurysms. Similarly, there was significant correlation between the absolute difference between the ipsilateral and contralateral TTs and aneurysm size (TT 10%-100% : P = 0.005, rho = 0.393; TT 25%-25% : P < 0.001, rho = 0.52) (Figure 2 ). Conclusion Our analysis shows that statistically significant difference in the intracranial contrast TT as a function of proximal aneurysm size. The mechanism for this might be related to the Windkessel effect where the aneurysm as a blood reservoir in systole and partially release the contrast in diastole. Changes to this baseline phenomenon might contribute to complications post flow diverters implementation. Introduction Carotid stenting (CAS) has been widely used since the seminal CREST trial, demonstrating equivalent results to carotid endarterectomy (CEA). With normal surgical risk patients having symptomatic or asymptomatic carotid artery disease, CAS and CEA, in qualified hands, have comparable outcomes, but patient-specific risk factors to estimate functional outcome were poorly studied. In practice, the choice between CEA and CAS is based on lesion anatomy and preference of patient and surgeon rather than considering defined risk factors associated with unfavorable outcome. We aimed to determine medical risk factors for poor functional outcome after CAS using the Healthcare Cost and Utilization Project Nationwide Inpatient Sample database (NIS) and formulate outcome prediction model to estimate unfavorable functional outcome. Methods We included 29,453 patients (age > 18) with symptomatic and asymptomatic carotid artery disease from 2005 to 2013, who underwent CAS using ICD-9 procedure code and diagnosis code for chronic and acute comorbidity as well as administration data including social economic and demographic profiles. Applying the non-parametric Jonckheere-Terpstra test, Multiple logistic regression, and multiple linear regression analyzes (SAS 9.4; SPSS 22) to formulate outcome prediction model using covariates for (1) Socio-economic status; age, sex and race, (2) chronic comorbidities; hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, congestive heart failure, atrial fibrillation/ flutter, COPD, chronic kidney disease, aortic/visceral/peripheral atherosclerosis, tobacco/alcohol dependence and morbid obesity, (3) care complexity; number of comorbidities, numbers of inpatient diagnosis/ procedures and (4) Acute comorbidities; acute myocardial infarct, acute kidney failure, pneumonia, acute respiratory failure and sepsis. We compared outcome markers which were defined as (1) procedure related stroke, (2) mortality, and (3) functional outcome based on discharge disposition; long term facility or not. Care complexity and acute comorbidities were also considered for outcome analysis without utilization for then outcome prediction formula because these variables are not predictable on admission. Results Mean age of symptomatic and asymptomatic CAS patients was 70.3 years (SD ± 10.6 years) with 20% > 80 years old; 39.5% females; 71.8% Whites, 4.5% Blacks and 4.1% Hispanics. 16.2% had symptomatic carotid stenosis. As chronic comorbidities, 75.7% had HTN, 32.1% DM, 58.1% HLD, 54.3% CAD, 0.6% CHF, 10.4% Atrial fibrillation/flutter 12.9% COPD, 11.4% chronic renal failure, 16.4% tobacco dependence, 0.4% alcohol dependence and 1.4% morbid obesity. As outcome makers, in-patient mortality was 1.1% (symptomatic 4.6%/asymptomatic 0.3%), 2% of patient had procedure related stroke (symptomatic 9.6%/asymptomatic 0.5%), discharge disposition to long term facility 9.4% (symptomatic 39.5%/asymptomatic 4.1%). Multiple outcome models developed to predict defined outcome markers to select the best predictable model. Introduction The Solitaire (Medtronic, Minneapolis, MN) is a stentriever device for endovascular treatment of acute ischemic stroke (AIS). The Solitaire is well described for use in temporary endovascular bypass, and mechanical thrombectomy. Permanent placement of the Solitaire is an option, but there are limited reports to date. The authors of this study review six cases of Solitaire stent implantation in the setting of large vessel occlusion and acute ischemic stroke, where temporary endovascular bypass and mechanical thrombectomy failed. Materials and methods Six cases of failed mechanical thrombectomy are reviewed, including procedural review, timing of anti-platelet agents, and radiographic and clinical outcomes. Results Six patients with severe, acute ischemic stroke (AIS) and large vessel occlusion (LVO) were triaged to mechanical thrombectomy. Despite multiple attempts at mechanical thrombus retrieval with a combination of devices including stentrievers and direct thrombus aspiration, flow could not be restored. As a bailout maneuver, the Solitaire stent was deployed and detached across the thrombus with TICI grade 3 flow restoration. All patients were loaded with full dose intra-arterial abciximab immediately after stent deployment and transitioned to dual antiplatelet therapy within 24 hours. There were no post-procedure hemorrhagic complications. All patients had significant neurological improvement post-procedurally, with favorable modified Rankin scores at follow-up. Conclusion With the recent over-whelming evidence demonstrating the effectiveness endovascular therapy in acute ischemic stroke, the expansion of stroke therapy requires that a variety of techniques be available to the operators. Permanent implantation of the Solitaire stent achieves adequate distal flow and good clinical outcomes in the setting of AIS. This case series suggests this technique provides a safe alternative for difficult cases refractory to other revascularization techniques. Key Words stroke, revascularization, stent Disclosures J. Houde: None. E. Barber: None. M. Kelly: 2; C; Medtronic. 4; C; Blockade. 6; C; Penumbra. L. Peeling: None.
